Gallbladder Adenocarcinoma Overview

Save information for later
Sign Up

Learn About Gallbladder Adenocarcinoma

View Main Condition: Gallbladder Cancer

What is the definition of Gallbladder Adenocarcinoma?
Gallbladder adenocarcinoma is a type of cancer that starts in gland-like cells that line the gallbladder. The gallbladder is a small pear-shaped organ below the liver that stores bile, which is a digestive fluid.
What are the symptoms of Gallbladder Adenocarcinoma?
Gallbladder adenocarcinoma may not have any symptoms until the late stages of the disease. Symptoms of gallbladder adenocarcinoma may include nausea and vomiting, loss of appetite, fever, abdominal bloating, abdominal pain in the right upper side, abdominal lumps, unexplained weight loss, itchy skin, dark urine, pale or greasy stools, and yellowing of the whites of the eyes and skin.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Gallbladder Adenocarcinoma?
Treatment for gallbladder adenocarcinoma depends on the stage, or how far it has progressed. Treatments for gallbladder adenocarcinoma include surgery, chemotherapy, radiation therapy, targeted drug therapy, and immunotherapy.
Who are the top Gallbladder Adenocarcinoma Local Doctors?
Timothy M. Pawlik
Elite in Gallbladder Adenocarcinoma
Dr. Timothy M. Pawlik
Surgical Oncology | General Surgery
Elite in Gallbladder Adenocarcinoma
Dr. Timothy M. Pawlik
Surgical Oncology | General Surgery

Osu Surgery, LLC

460 W 10th Ave, 
Columbus, OH 
614-293-2101
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Timothy Pawlik is a Surgical Oncologist and a General Surgeon in Columbus, Ohio. Dr. Pawlik is rated as an Elite provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Pancreatic Cancer, Gallbladder Adenocarcinoma, Cholangiocarcinoma (Bile Duct Cancer), Hepato-Pancreato-Biliary Surgery, and Pancreaticoduodenectomy. Dr. Pawlik is currently accepting new patients.

Laleh G. Melstrom
Distinguished in Gallbladder Adenocarcinoma
Dr. Laleh G. Melstrom
General Surgery | Surgical Oncology
Distinguished in Gallbladder Adenocarcinoma
Dr. Laleh G. Melstrom
General Surgery | Surgical Oncology

City Of Hope Medical Foundation

1500 Duarte Rd, 
Duarte, CA 
626-256-4673
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Laleh Melstrom is a General Surgeon and a Surgical Oncologist in Duarte, California. Dr. Melstrom is rated as a Distinguished provider by MediFind in the treatment of Gallbladder Adenocarcinoma. Her top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Small Bowel Resection.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Gallbladder Adenocarcinoma
Dr. Ghassan K. Abou-Alfa
Oncology
Elite in Gallbladder Adenocarcinoma
Dr. Ghassan K. Abou-Alfa
Oncology

Memorial Solid Tumor Group

1275 York Ave, 
New York, NY 
212-639-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ghassan Abou-Alfa is an Oncologist in New York, New York. Dr. Abou-Alfa is rated as an Elite provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Liver Cancer, Cholangiocarcinoma (Bile Duct Cancer), Fibrolamellar Carcinoma, Liver Embolization, and Pancreaticoduodenectomy.

View All Doctors
What are the latest Gallbladder Adenocarcinoma Clinical Trials?
Evaluating Novel Therapies and ctDNA as a Marker in Curatively-Treated Gastrointestinal Cancers With Microscopic Residual Disease
Evaluating Novel Therapies and ctDNA as a Marker in Curatively-Treated Gastrointestinal Cancers With Microscopic Residual Disease
Enrollment Status: Recruiting
Publish Date: May 22, 2025
Intervention Type: Drug
Study Phase: Phase 3

Summary: This study is a non-randomized, open-label, multi-cohort, multi-site, pilot feasibility therapeutic trial. The study will enroll 20 patients across 4 cohorts (CRC, gastric, PDAC, and HCC/intra-hepatic-/extra-hepatic-, gall bladder adenocarcinomas) diagnosed with histologically confirmed GI cancers. These patients will have already completed all Standard of Care (SOC) treatments (including neoadjuv...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Safety and Feasibility of Prophylactic Heated Intra-peritoneal Chemotherapy (HIPEC) for High-Risk Gallbladder Adenocarcinoma
Safety and Feasibility of Prophylactic Heated Intra-peritoneal Chemotherapy (HIPEC) for High-Risk Gallbladder Adenocarcinoma
Enrollment Status: Recruiting
Publish Date: February 24, 2025
Intervention Type: Drug
Study Phase: Early Phase 1

Summary: Gallbladder adenocarcinoma is a devastating disease associated with a poor prognosis. Gallbladder and other biliary cancers will be responsible for an estimated 11,980 new cases, and 4,090 deaths in the US during 2020. The 5-year survival for all patients with gallbladder cancer is 18%, however this plummets to 2% for patients with metastatic disease. Patients with gallbladder cancer frequently de...

View All Clinical Trials